While I was quick to criticize, I also have no problem admitting when I was wrong.

That’s the beauty of being 100% independent and not having to worry about keeping up any professional appearances.

And I was happily wrong about the pricing of Provention Bio’s (PRVB) offering.

If my harshness in any way inspired them to “show me” by pricing a better deal, awesome!

Here’s what’s important, including key data shared during presentations at the 80th annual American Diabetes Association (ADA) annual meeting that have not been broadly distributed by the company…


This content is reserved for subscribers. To gain immediate access to our 100% independent research on the top tech trends and companies before they become household names, consider subscribing here.